Merck
CN
  • Microglia replacement by microglia transplantation (Mr MT) in the adult mouse brain.

Microglia replacement by microglia transplantation (Mr MT) in the adult mouse brain.

STAR protocols (2021-07-27)
Zhen Xu, Bo Peng, Yanxia Rao
摘要

Mutations in microglia may cause brain disorders. Replacement of dysfunctional microglia by allogeneic wild-type microglia from bone marrow transplantation (Mr BMT) or peripheral blood can correct the gene deficiency at the brain-wide scale but cannot achieve precise replacement at specific brain regions. Here, we introduce a strategy with potential clinical relevance-microglia replacement by microglia transplantation (Mr MT), combining tamoxifen-induced ablation of Mr BMT cells and intracranial injection of microglia to mouse brain, to achieve region-sepcific microglia replacement. The original abbreviation of this microglia replacement strategy is mrMT. We hereby change the name to Mr MT. For complete details on the use and execution of this protocol, please refer to Xu et al. (2020).

材料
货号
品牌
产品描述

Sigma-Aldrich
二甲基亚砜, Hybri-Max, sterile-filtered, BioReagent, suitable for hybridoma, ≥99.7%
Sigma-Aldrich
胆固醇, Sigma Grade, ≥99%
Sigma-Aldrich
N-乙酰基-L-半胱氨酸, suitable for cell culture, BioReagent
Sigma-Aldrich
L-半胱氨酸, 97%
Sigma-Aldrich
脱铁转铁蛋白 人, powder, BioReagent, suitable for cell culture, ≥98% (agarose gel electrophoresis)
Sigma-Aldrich
油酸, suitable for cell culture, BioReagent
Sigma-Aldrich
甲苯噻嗪 盐酸盐, ≥99.0% (HPLC)
Sigma-Aldrich
顺式-11-二十碳烯酸, ≥99% (capillary GC)
Sigma-Aldrich
Meloxicam sodium salt hydrate, ≥98% (HPLC)